Insider Shareholders with Direct Ownership of Quoin Pharmaceuticals, Ltd. (QNRX)
This section provides a comprehensive overview of the insiders with direct ownership of Quoin Pharmaceuticals, Ltd. (QNRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Quoin Pharmaceuticals, Ltd. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Michael Myers
Chief Executive Officer |
37,894 | 0 | 47,252 $25,043 | 2 |
Sep 04, 2024
Added 33.28%
|
Denise P. Carter
Chief Operating Officer |
37,735 | 0 | 47,092 $24,958 | 2 |
Sep 04, 2024
Added 32.8%
|
Gordon Dunn
Chief Financial Officer |
28,856 | 0 | 28,856 $15,293 | 2 |
Sep 10, 2024
Added 25.74%
|
Dennis Langer
Director |
0 | 297 | 53 $28 | 1 |
Jun 07, 2024
Reduced 84.86%
|